Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P4501B1

被引:166
作者
Choudhary, D
Jansson, I
Stoilov, I
Sarfarazi, M
Schenkman, JB
机构
[1] Univ Connecticut, Ctr Hlth, Dept Pharmacol, Farmington, CT 06030 USA
[2] Univ Connecticut, Ctr Hlth, Dept Surg, Mol Ophthalm Genet Lab, Farmington, CT 06030 USA
关键词
D O I
10.1124/dmd.32.8.840
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The cytochrome P450 family 1 (CYP1) is considered to be one of the xenobiotic-metabolizing enzyme families and is responsible for oxidative metabolism of polycyclic aromatic hydrocarbons. For example, mouse Cyp1b1 was originally identified as the enzyme responsible for oxidative metabolism of 7,12-dimethylbenz(alpha) anthracene ( DMBA). A comparison of the kinetics of this metabolism by mouse and human CYP1B1 orthologs revealed the mouse enzyme to have a more favorable metabolism of DMBA, with a catalytic efficiency ratio (CER) of 0.23. However, CYP1 enzymes are also capable of metabolism of endobiotics, and in the present study, the metabolism of retinoids and lipid endobiotics by human CYP1B1 and mouse Cyp1b1 orthologs was compared. Both hemoproteins oxidized retinol to retinal and retinal to retinoate, but did not oxidize retinoate. The CYP1B1 to Cyp1b1 CERs were 13 and 26 for the two steps, respectively; the Cyp1b1 K-m(app) values for retinoids were 20-fold higher. Human family 1 cytochromes P450 had unique regional specificities for arachidonate oxidation: the major metabolites of CYP1A1, CYP1A2, and CYP1B1 were 75% terminal hydroxyeicosatetraenoic fatty acids (HETEs), 52% epoxyeicosatrienoic fatty acids (EETs), and 54% mid-chain HETEs, respectively. CYP1A1 and CYP1B1 K-m(app) values for arachidonate were about 30 muM, whereas CYP1A2 K-m(app) was 95 muM. The major metabolites of arachidonic acid by Cyp1b1 were EETs (50%) and midchain HETEs (37%). The mouse ortholog had a CER for metabolite production of 64 due to a K-m(app) of 0.5 mM for arachidonate.
引用
收藏
页码:840 / 847
页数:8
相关论文
共 43 条
[1]   7-HETE, 1O-HETE, AND 13-HETE ARE MAJOR PRODUCTS OF NADPH-DEPENDENT ARACHIDONIC-ACID METABOLISM IN RAT-LIVER MICROSOMES - ANALYSIS OF THEIR STEREOCHEMISTRY, AND THE STEREOCHEMISTRY OF THEIR ACID-CATALYZED REARRANGEMENT [J].
BRASH, AR ;
BOEGLIN, WE ;
CAPDEVILA, JH ;
YEOLA, S ;
BLAIR, IA .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1995, 321 (02) :485-492
[2]   cDNA cloning and expression of CYP4F12, a novel human cytochrome P450 [J].
Bylund, J ;
Bylund, M ;
Oliw, EH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 280 (03) :892-897
[3]  
Bylund J, 1998, J PHARMACOL EXP THER, V284, P51
[4]   The CYPP450 arachidonic acid monooxygenases: From cell signaling to blood pressure regulation [J].
Capdevila, JH ;
Falck, JR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 285 (03) :571-576
[5]   A decade of molecular biology of retinoic acid receptors [J].
Chambon, P .
FASEB JOURNAL, 1996, 10 (09) :940-954
[6]  
Chen H, 2000, DRUG METAB DISPOS, V28, P315
[7]  
DAIKH BE, 1994, J PHARMACOL EXP THER, V271, P1427
[8]  
FALCK JR, 1990, J BIOL CHEM, V265, P10244
[9]   HIGH-LEVEL EXPRESSION OF FUNCTIONAL HUMAN CYTOCHROME-P450 1A2 IN ESCHERICHIA-COLI [J].
FISHER, CW ;
CAUDLE, DL ;
MARTINWIXTROM, C ;
QUATTROCHI, LC ;
TUKEY, RH ;
WATERMAN, MR ;
ESTABROOK, RW .
FASEB JOURNAL, 1992, 6 (02) :759-764
[10]   Metabolic inactivation of retinoic acid by a novel P450 differentially expressed in developing mouse embryos [J].
Fujii, H ;
Sato, T ;
Kaneko, S ;
Gotoh, O ;
FujiiKuriyama, Y ;
Osawa, K ;
Kato, S ;
Hamada, H .
EMBO JOURNAL, 1997, 16 (14) :4163-4173